Rishabh Instrum. Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 24 May 2026 | Electrical Equipment | Market Cap: ₹2.5K Cr
EEI business expected to grow 20%-25% top line annually, targeting around INR670 crores in FY27 from INR560 crores currently. - U.S. EEI (Electrical & Electronics Instrumentation) business expected to grow 20-25% top line in FY27.
From Rishabh Instrum.'s Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹669
Market Cap
₹2.5K Cr
P/E Ratio
31.0
Revenue Rank
Margin Rank
How does Rishabh Instrum. rank in Electrical Equipment?
Compare Rishabh Instrum. against every Electrical Equipment company this quarter on revenue, margins and earnings-call signals.
Rishabh Instrum. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹205 Cr, net profit ₹20 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →EEI business expected to grow 20%-25% top line annually, targeting around INR670 crores in FY27 from INR560 crores currently.
- →U.S. market sales have grown 50% YoY recently, with plan to increase from USD3 million to 40%-50% higher next year; target INR100 crores business from U.S. in 3-4 years.
- →Alucast segment expected to have flat or slightly lower revenues (~below INR200 crores in FY27) with focus on achieving breakeven and improving margins.
- →Solar inverter business targeting INR24-25 crores revenues in FY27, with capacity to scale up to INR100 crores in new plant.
- →Overall consolidated revenue may approach INR1,000 crores by March 2028 with EBITDA around INR150-160 crores, possibly closer to INR200 crores by then.
- →Other smaller divisions expected to grow faster (~30%) than main EEI business (~20%).
📈 Profitability & Margins
Rank 3- →EEI (Electrical & Electronics Instrumentation) business expected to grow 20-25% top line in FY27.
- →EBITDA margin guidance for EEI segment maintained at 20-22%, with potential fluctuations due to product mix.
- →Overall consolidated EBITDA growth projected around 20% but with cautious margins due to geopolitical and operational factors.
- →Lumel and Rishabh Instruments expected to grow at ~20% top line, while smaller entities may grow faster (~30%).
- →EBITDA may improve with operating leverage but conservatively guided at 20-22%.
- →Alucast (die casting business) expected to be flat or slightly below previous revenue with focus on cost control and profitability.
- →By March 2028, potential to approach INR 1,000 crore revenue and INR 200 crore EBITDA consolidated, though crossing INR 1,000 crore is not guaranteed.
- →Continued R&D and capacity expansions in solar and medium voltage products expected to drive growth.
- →EPS growth expected to follow revenue and margin expansion but specific figures not disclosed.
🏗️ Capital Expenditure Plans
Yes- →Nashik expansion capex completed with 2 new manufacturing facilities nearly ready, doubling production capacity to meet rising demand.
- →New building under construction with one entire floor dedicated to solar inverter manufacturing; assembly lines to ramp up production.
- →Incremental investment planned to scale solar inverter capacity up to INR100 crores.
- →Expansion planned for medium voltage products (CTs, PTs, VTs), solar products, and cam switches.
- →Focus on developing and certifying products for high-growth markets like the U.S., with plans to increase current transformer capacity from 6,000 to 10,000 units/day.
- →Exploring inorganic growth opportunities including potential acquisitions in the U.S. and Europe to speed market entry and product certifications.
- →Organic growth remains core; reinvesting profits from business for further expansion.
💰 Fundraising & Capital Structure
No information- →There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
- →The company remains net debt free with a strong balance sheet and had net cash and cash equivalents of INR1,276 million as of March 31, 2026.
- →They discussed plans for organic growth and capacity expansion, mainly funded through internal accruals and incremental investments (e.g., new manufacturing setups).
- →No concrete plans or announcements were made regarding acquisitions or fundraising but acquisitions in the U.S. market are being considered to accelerate market entry.
- →Overall, the company appears focused on organic growth and strategic investments without indicating immediate fundraising via debt or equity.
📋 Order Book & Pipeline
Yes- →The company has a concrete pipeline for new orders based on substantial efforts.
- →They have submitted several crores worth of offers.
- →Numerous customer visits and audits have been conducted.
- →Several orders have been cleared and negotiations are ongoing.
- →Currently, they are negotiating prices and other business conditions with multiple prospects.
- →There are at least 3 to 4 new prospective customers in the negotiation phase.
- →Additionally, 2 to 3 existing customers are providing new projects.
- →This order pipeline is based on real data and not just aspirational thinking.
- →The order pipeline supports the company's 2-year projection to return to better revenue and margin figures.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Rishabh Instrum. Q4 FY26 results?
EEI business expected to grow 20%-25% top line annually, targeting around INR670 crores in FY27 from INR560 crores currently. - U.S. EEI (Electrical & Electronics Instrumentation) business expected to grow 20-25% top line in FY27.
What is Rishabh Instrum. share price analysis?
Rishabh Instrum. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 31.0 with a market cap of ₹2,510 Cr. Investors should review the full earnings analysis for detailed insights.
Is Rishabh Instrum. planning capital expenditure?
Nashik expansion capex completed with 2 new manufacturing facilities nearly ready, doubling production capacity to meet rising demand.
Keep Rishabh Instrum. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.